Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait

Author of the article: Physical Therapists Who Visit Booth 512 Can Sign Up for Free Online PoNS Therapy™ Training NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) — Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American Congress of Rehabilitation Medicine (ACRM) Conference, held November 8-11…
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait

Author of the article:

Physical Therapists Who Visit Booth 512 Can Sign Up for Free Online PoNS Therapy™ Training

NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) — Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American Congress of Rehabilitation Medicine (ACRM) Conference, held November 8-11 in Chicago. Visitors to booth 512 will see the device and learn more about how it can improve gait deficiency in people with multiple sclerosis (MS).

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

PoNS works by delivering electrical impulses through nerve fibers on the tongue, stimulating the flow of millions of neural impulses to the brain structures that control gait. This creates a cascade of activity in the brain that – when combined with an exercise regimen supervised by a physical therapist – produces a neuromodulatory and neuroplastic effect that can have a significant impact on the independence and personal productivity of people with MS. (Results of this study can be found at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017705/)

“The ACRM is committed to helping people live their fullest lives by improving, expanding and regaining mobility, and we’re excited to exhibit at the Conference because we share the same goals,” said Antonella Favit-Van Pelt, M.D., Ph.D., Helius’ Chief Medical Officer. “PoNS addresses a complication that’s very top-of-mind for people with MS: 70% of them report having difficulty walking, and of that group 70% identify gait deficit as the most challenging aspect of their disease.”

In addition to seeing the PoNS device in person, booth visitors can speak with key Helius team members, who can answer questions about PoNS and the accompanying PoNS Therapy regimen that maximizes its effectiveness. Physical therapists also will be able to sign up for free, online PoNS Therapy training.

“Rehabilitation professionals who work with people with MS, or are interested in the relationship between neuromodulation and gait, are invited to visit us at booth 512,” said Favit-Van Pelt. “But this is more than just a chance to see the device and talk, it’s an opportunity to take action: By signing up for training physical therapists are making themselves even more invaluable to their patients with MS.”

About Helius Medical Technologies, Inc.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS®). For more information, visit www.heliusmedical.com.

About the PoNS Device and PoNS Therapy

The Portable Neuromodulation Stimulator (PoNS) is an innovative non-surgical medical device, inclusive of a controller and mouthpiece, which delivers electrical stimulation to the surface of the tongue to improve balance and gait. The PoNS device is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. Helius is advancing PoNS post-approval research in MS through a recently launched Therapeutic Experience Program (TEP) designed to partner with neurologists and neurorehabilitation therapists at 10-12 US centers of excellence, who express an interest in becoming “early adopters” of PoNS therapy. For more information visit www.ponstherapy.com.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
H.I.G. Capital Announces the Sale of Sustana
Read More

H.I.G. Capital Announces the Sale of Sustana

Author of the article: MIAMI — H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $45 billion of equity capital under management, is pleased to announce the sale of its portfolio company Sustana Group (“Sustana” or the “Company”) to funds managed by Blackstone Tactical Opportunities (“Blackstone”). Sustana is a leading manufacturer of specialty…
Mexico expects EU trade deal to be approved in 2022, minister says
Read More

Mexico expects EU trade deal to be approved in 2022, minister says

Author of the article: MEXICO CITY — The European Union should sign off on its updated trade agreement with Mexico later this year, Mexican Foreign Minister Marcelo Ebrard said on Friday. The EU and Latin America’s second-biggest economy in 2018 reached an agreement in principle on updating their joint trade deal, but the coronavirus pandemic…
China EV Maker Leapmotor Aims to Raise Up to $1 Billion in IPO
Read More

China EV Maker Leapmotor Aims to Raise Up to $1 Billion in IPO

Chinese electric-vehicle maker Zhejiang Leapmotor Technology Co. is looking to raise as much as HK$8.1 billion ($1 billion) in an initial public offering in Hong Kong. Author of the article: Bloomberg News Filipe Pacheco and Pei Li WUHAN, CHINA - OCTOBER Photo by Getty Images /Photographer: Getty Images/Getty (Bloomberg) — Chinese electric-vehicle maker Zhejiang Leapmotor…
Russian aviation sector isolated as Boeing suspends parts, maintenance
Read More

Russian aviation sector isolated as Boeing suspends parts, maintenance

Author of the article: Reuters Jamie Freed and David Shepardson U.S. airplane manufacturer Boeing said it was suspending parts, maintenance and technical support for Russian airlines as the effect of sanctions in the wake of Russia’s invasion of Ukraine ripple across the global aviation industry. The United States said it would follow the European Union…